摘要
急性冠状动脉综合征(ACS)目前仍然是内科疾病中最急危重症之一。尽管近年来各种预防及治疗措施的不断改进使得该病的发病率和病死率显著下降,但该类患者一旦发病仍面临较高的复发率及病死率。经皮冠状动脉介入手术治疗ACS的效果优良,但并非所有ACS患者都能实施手术治疗,相当一部分患者出于各种原因只能通过药物非手术治疗。该文就ACS患者非血运重建治疗,即单纯药物治疗的进展予以综述。
Acute coronary syndrome（ACS） remains one of the highest-risk diseases among acute medical admissions. Despite significant reduction in morbidity and mortality via refinements in treatment in recent years, some individuals are still facing a high risk of recurrent ischemic events and death. The efficiency of pereutaneous coronary intervention（PCI） has already been confirmed by a large amount of clinical trials, but not all the patients with ACS can be remedied by the operation of PCI, a considerable number of patientscould only be treated by drugs for some reasons. Here is to review the development of the non-revascularization therapy, namely only medication treatment, in ACS patients.
出处
《医学综述》
2014年第24期4523-4526,共4页
Medical Recapitulate
